Advancing Aseptic Drug Product Manufacturing for High-Value Biologics Through Robotics: Protecting Product, Process and Patient

Automation and robotics are rapidly becoming the new standard in drug product manufacturing, driven by rising quality requirements, operational efficiency goals and the implementation of EU GMP Annex 1. For aseptic fill-finish, robotic systems enable higher process consistency, reduced human intervention and improved contamination control. At the same time, advanced automation supports greater flexibility, data integrity and reproducibility across production processes. This presentation explores how robotics and automation are reshaping fill-finish operations, the role they play in Annex 1 compliance and why they are increasingly seen not only as a technological advantage, but as a strategic necessity for future-ready pharmaceutical production.